Global Veterinary Drugs 麻豆原创 Research Report 2024

Publication ID:

PB504247838

Publication Date:

April 29, 2024

Pages:

Publisher:

MRRPB5

Countries:

Global [1]

USD 2,900.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

Veterinary drugs are used to cure and prevent diseases in animals, including animals used for food production. Veterinary drugs are given to animals via feed or drinking water, or by injection.
The global Veterinary Drugs market was valued at US$ 23720 million in 2023 and is anticipated to reach US$ 34770 million by 2030, witnessing a CAGR of 5.5% during the forecast period 2024-2030.
Pet medical care is the second largest segment in pet industry. In the UK, annual spending on veterinary and other pet services has risen from 拢2.6bn in 2015 to 拢4bn in 2021, a 54% increase in just six years. According to Vetnosis, the value of the global animal health industry will increase by 12% to $38.3 billion in 2021. White Paper on China's Pet Healthy Consumption of JD shows that in 2023, there are 13.09 million pets entering middle age and old age. And pet aging is expected to be seen in the next few years. Changes in the age structure of pets will further bring about the development of the pet medical industry. According to the data of the 2022 China Pet Medical Industry White Paper, from the perspective of market size, the scale of China's pet medical market is about 楼67.5 billion, accounting for about 22.5% of the entire pet industry. From the perspective of hospital operation time, pet hospitals within 5 years accounted for about 73%. About 11% of the pet hospitals have been in operation for more than 10 years. From the perspective of hospital turnover, nearly 40% of the hospitals have increased their annual turnover year-on-year, and the growth rate is mainly within 23%.
This report aims to provide a comprehensive presentation of the global market for Veterinary Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Veterinary Drugs.
Report Scope
The Veterinary Drugs market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Veterinary Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Veterinary Drugs companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
麻豆原创 Segmentation
By Company
Zoetis Inc.
Boehringer Ingelheim Animal Health
Merck Animal Health
Elanco
Bayer AG
Ceva Sante Animale S.A.
Virbac SA
Vetoquinol SA
IDEXX Laboratories, Inc.
Covetrus, Inc.
Segment by Type
Treatment Drugs
Vaccines
Others
Segment by Application
Chickens
Swine
Cattle
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Veterinary Drugs companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global Veterinary Drugs 麻豆原创 Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Treatment Drugs
1.2.3 Vaccines
1.2.4 Others
1.3 麻豆原创 by Application
1.3.1 Global Veterinary Drugs 麻豆原创 Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Chickens
1.3.3 Swine
1.3.4 Cattle
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Veterinary Drugs 麻豆原创 Perspective (2019-2030)
2.2 Veterinary Drugs Growth Trends by Region
2.2.1 Global Veterinary Drugs 麻豆原创 Size by Region: 2019 VS 2023 VS 2030
2.2.2 Veterinary Drugs Historic 麻豆原创 Size by Region (2019-2024)
2.2.3 Veterinary Drugs Forecasted 麻豆原创 Size by Region (2025-2030)
2.3 Veterinary Drugs 麻豆原创 Dynamics
2.3.1 Veterinary Drugs Industry Trends
2.3.2 Veterinary Drugs 麻豆原创 Drivers
2.3.3 Veterinary Drugs 麻豆原创 Challenges
2.3.4 Veterinary Drugs 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top Veterinary Drugs Players by Revenue
3.1.1 Global Top Veterinary Drugs Players by Revenue (2019-2024)
3.1.2 Global Veterinary Drugs Revenue 麻豆原创 Share by Players (2019-2024)
3.2 Global Veterinary Drugs 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Veterinary Drugs Revenue
3.4 Global Veterinary Drugs 麻豆原创 Concentration Ratio
3.4.1 Global Veterinary Drugs 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Veterinary Drugs Revenue in 2023
3.5 Veterinary Drugs Key Players Head office and Area Served
3.6 Key Players Veterinary Drugs Product Solution and Service
3.7 Date of Enter into Veterinary Drugs 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 Veterinary Drugs Breakdown Data by Type
4.1 Global Veterinary Drugs Historic 麻豆原创 Size by Type (2019-2024)
4.2 Global Veterinary Drugs Forecasted 麻豆原创 Size by Type (2025-2030)
5 Veterinary Drugs Breakdown Data by Application
5.1 Global Veterinary Drugs Historic 麻豆原创 Size by Application (2019-2024)
5.2 Global Veterinary Drugs Forecasted 麻豆原创 Size by Application (2025-2030)
6 North America
6.1 North America Veterinary Drugs 麻豆原创 Size (2019-2030)
6.2 North America Veterinary Drugs 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Veterinary Drugs 麻豆原创 Size by Country (2019-2024)
6.4 North America Veterinary Drugs 麻豆原创 Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Veterinary Drugs 麻豆原创 Size (2019-2030)
7.2 Europe Veterinary Drugs 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Veterinary Drugs 麻豆原创 Size by Country (2019-2024)
7.4 Europe Veterinary Drugs 麻豆原创 Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Veterinary Drugs 麻豆原创 Size (2019-2030)
8.2 Asia-Pacific Veterinary Drugs 麻豆原创 Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Veterinary Drugs 麻豆原创 Size by Region (2019-2024)
8.4 Asia-Pacific Veterinary Drugs 麻豆原创 Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Veterinary Drugs 麻豆原创 Size (2019-2030)
9.2 Latin America Veterinary Drugs 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Veterinary Drugs 麻豆原创 Size by Country (2019-2024)
9.4 Latin America Veterinary Drugs 麻豆原创 Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Veterinary Drugs 麻豆原创 Size (2019-2030)
10.2 Middle East & Africa Veterinary Drugs 麻豆原创 Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Veterinary Drugs 麻豆原创 Size by Country (2019-2024)
10.4 Middle East & Africa Veterinary Drugs 麻豆原创 Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Zoetis Inc.
11.1.1 Zoetis Inc. Company Detail
11.1.2 Zoetis Inc. Business Overview
11.1.3 Zoetis Inc. Veterinary Drugs Introduction
11.1.4 Zoetis Inc. Revenue in Veterinary Drugs Business (2019-2024)
11.1.5 Zoetis Inc. Recent Development
11.2 Boehringer Ingelheim Animal Health
11.2.1 Boehringer Ingelheim Animal Health Company Detail
11.2.2 Boehringer Ingelheim Animal Health Business Overview
11.2.3 Boehringer Ingelheim Animal Health Veterinary Drugs Introduction
11.2.4 Boehringer Ingelheim Animal Health Revenue in Veterinary Drugs Business (2019-2024)
11.2.5 Boehringer Ingelheim Animal Health Recent Development
11.3 Merck Animal Health
11.3.1 Merck Animal Health Company Detail
11.3.2 Merck Animal Health Business Overview
11.3.3 Merck Animal Health Veterinary Drugs Introduction
11.3.4 Merck Animal Health Revenue in Veterinary Drugs Business (2019-2024)
11.3.5 Merck Animal Health Recent Development
11.4 Elanco
11.4.1 Elanco Company Detail
11.4.2 Elanco Business Overview
11.4.3 Elanco Veterinary Drugs Introduction
11.4.4 Elanco Revenue in Veterinary Drugs Business (2019-2024)
11.4.5 Elanco Recent Development
11.5 Bayer AG
11.5.1 Bayer AG Company Detail
11.5.2 Bayer AG Business Overview
11.5.3 Bayer AG Veterinary Drugs Introduction
11.5.4 Bayer AG Revenue in Veterinary Drugs Business (2019-2024)
11.5.5 Bayer AG Recent Development
11.6 Ceva Sante Animale S.A.
11.6.1 Ceva Sante Animale S.A. Company Detail
11.6.2 Ceva Sante Animale S.A. Business Overview
11.6.3 Ceva Sante Animale S.A. Veterinary Drugs Introduction
11.6.4 Ceva Sante Animale S.A. Revenue in Veterinary Drugs Business (2019-2024)
11.6.5 Ceva Sante Animale S.A. Recent Development
11.7 Virbac SA
11.7.1 Virbac SA Company Detail
11.7.2 Virbac SA Business Overview
11.7.3 Virbac SA Veterinary Drugs Introduction
11.7.4 Virbac SA Revenue in Veterinary Drugs Business (2019-2024)
11.7.5 Virbac SA Recent Development
11.8 Vetoquinol SA
11.8.1 Vetoquinol SA Company Detail
11.8.2 Vetoquinol SA Business Overview
11.8.3 Vetoquinol SA Veterinary Drugs Introduction
11.8.4 Vetoquinol SA Revenue in Veterinary Drugs Business (2019-2024)
11.8.5 Vetoquinol SA Recent Development
11.9 IDEXX Laboratories, Inc.
11.9.1 IDEXX Laboratories, Inc. Company Detail
11.9.2 IDEXX Laboratories, Inc. Business Overview
11.9.3 IDEXX Laboratories, Inc. Veterinary Drugs Introduction
11.9.4 IDEXX Laboratories, Inc. Revenue in Veterinary Drugs Business (2019-2024)
11.9.5 IDEXX Laboratories, Inc. Recent Development
11.10 Covetrus, Inc.
11.10.1 Covetrus, Inc. Company Detail
11.10.2 Covetrus, Inc. Business Overview
11.10.3 Covetrus, Inc. Veterinary Drugs Introduction
11.10.4 Covetrus, Inc. Revenue in Veterinary Drugs Business (2019-2024)
11.10.5 Covetrus, Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Companies Mentioned:

Zoetis Inc.
Boehringer Ingelheim Animal Health
Merck Animal Health
Elanco
Bayer AG
Ceva Sante Animale S.A.
Virbac SA
Vetoquinol SA
IDEXX Laboratories, Inc.
Covetrus, Inc.

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.